Gedeon Richter files biosimilar RoActemra with European agency
- ByInvesting.com-
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
25,760.0 | 26,060.0 | 25,100.0 | +30.0 | +0.12% | 677.47K | ||
2,926.0 | 2,926.0 | 2,868.0 | +24.0 | +0.83% | 885.08K | ||
10,080.0 | 10,160.0 | 10,040.0 | -50.0 | -0.49% | 153.09K | ||
1,810.0 | 1,810.0 | 1,746.0 | +42.0 | +2.38% | 2.65M | ||
1,450.0 | 1,455.0 | 1,440.0 | -10.0 | -0.68% | 2.54K | ||
8,480.0 | 8,600.0 | 8,400.0 | 0.0 | 0.00% | 21.37K | ||
54.100 | 54.400 | 53.200 | -0.300 | -0.55% | 70.28K | ||
367.0 | 369.0 | 359.0 | -1.0 | -0.27% | 2.92K | ||
677.0 | 693.0 | 662.0 | -21.0 | -3.01% | 93.87K | ||
12.5 | 12.7 | 12.5 | -0.1 | -0.79% | 933 | ||
546.00 | 554.00 | 542.00 | -4.00 | -0.73% | 211.34K | ||
1,752.0 | 1,778.0 | 1,736.0 | -8.0 | -0.45% | 121.47K | ||
2,420.0 | 2,420.0 | 2,320.0 | +90.0 | +3.86% | 6K | ||
5,300.0 | 5,300.0 | 5,160.0 | +20.0 | +0.38% | 2.59K | ||
4,900.00 | 4,950.00 | 4,870.00 | -30.00 | -0.61% | 3K | ||
159.00 | 159.00 | 157.50 | -1.00 | -0.63% | 39.9K |
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Investing.com -- Shares of MOL Group (BUD:MOL) fell by 1% following the release of its fourth-quarter results, which showed Clean...
Investing.com -- Despite European equities reaching all-time highs, 66% of fund managers expect further near-term gains, according...
No Earning Reports have been scheduled